LLAI - Ticker AI Digest

LungLife AI Inc 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (LLAI) 1
LLAI 06:01
LungLife AI Inc
Notice of Special Meeting
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 1
LLAI 06:01
LungLife AI Inc
License Agreement and Other Matters
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
LungLife AI, a developer of clinical diagnostic solutions for lung cancer, has entered into an exclusive license and distribution agreement with Circulogene Theranostics, a US liquid biopsy diagnostics company. The agreement grants Circulogene the exclusive rights to improve, develop, market, and sell LungLifes LungLB® <mark style="background-color:yellow">test</mark> in the US, along with its software and intellectual property. LungLife will receive an advanced payment of $375,000, followed by a second payment of the same amount upon completion of the agreement. LungLife will also receive royalty payments of 20% of net revenue collected by Circulogene for the first year, with a minimum guaranteed amount. The agreement includes an asset purchase option for Circulogene to acquire LungLifes licensed IP and equipment for $6.2 million. LungLifes CEO, Paul Pagano, expresses enthusiasm for the partnership, while Circulogenes CEO, Mike Mullen, highlights the potential impact of LungLB® on lung cancer detection. The agreement is expected to reduce LungLifes operating activity, leading to a proposed cancellation of its admission to trading on AIM, with shareholder approval to be sought.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 2
LLAI 06:01
LungLife AI Inc
Notice of Special Meeting
LLAI 06:01
LungLife AI Inc
License Agreement and Other Matters
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
LungLife AI, a developer of clinical diagnostic solutions for lung cancer, has entered into an exclusive license and distribution agreement with Circulogene Theranostics, a US liquid biopsy diagnostics company. The agreement grants Circulogene the exclusive rights to improve, develop, market, and sell LungLifes LungLB® <mark style="background-color:yellow">test</mark> in the US, along with its software and intellectual property. LungLife will receive an advanced payment of $375,000, followed by a second payment of the same amount upon completion of the agreement. LungLife will also receive royalty payments of 20% of net revenue collected by Circulogene for the first year, with a minimum guaranteed amount. The agreement includes an asset purchase option for Circulogene to acquire LungLifes licensed IP and equipment for $6.2 million. LungLifes CEO, Paul Pagano, expresses enthusiasm for the partnership, while Circulogenes CEO, Mike Mullen, highlights the potential impact of LungLB® on lung cancer detection. The agreement is expected to reduce LungLifes operating activity, leading to a proposed cancellation of its admission to trading on AIM, with shareholder approval to be sought.

AI Crunch

Single-Ticker AI Crunch
LLAI signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for LungLife AI Inc. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full LLAI AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for LLAI on 2025-04-29.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
1302992
Enterprise Value
20284558
Public Float
36.96
Broker Target
171
Shares Out
30658600
Long Interest
-
Short Interest
-
Exchange
LSE
Currency Code
GBX
ISIN
USU5500L1045
Market
None
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
-
Net Debt
-2378000.0
Cash
2724000.0
EPS
-0.12
Net Income
-5413000.0
Revenue
46000.0
Enterprise Value
20284558
Trailing PE
-
Forward PE
-
Price Sales TTM
44.9308
Price Book MRQ
0.2167
EV Revenue
564.0165
EV EBITDA
-1.8632

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
17.64
Institutions As Of
2025-05-27
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
6
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
1
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit LLAI.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2025-04-29 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
LungLife AI Inc has fresh news flow feeding the chart narrative.
06:01 Today's Catalyst Notice of Special Meeting
AI Charts Studio
LLAI Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-04-29 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
RSI Gauge
Price Change
AI Forecast